Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Gossamer Bio, Inc. Filed by: DeepCurrents Investment Group LLC

June 11, 2026 8:11 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figure in Item 6 represents shares of Common Stock, $0.0001 par value per share ("Common Stock") of Gossamer Bio, Inc. (the "Issuer") held by DCIG Capital Master Fund LP, a Delaware limited partnership (the "Fund"). (2) The figures in Items 8 and 9 include: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figures in Items 6, 8, and 9 represent shares of Common Stock held by the Fund. (2) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figure in Items 6 represents shares of Common Stock held by the Fund. (2) The figures in Items 8 and 9 includes: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G



DeepCurrents Investment Group LLC
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member and President
Date:06/11/2026
DCIG GP LLC
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
DCIG Capital Master Fund LP
Signature:DCIG GP LLC
Name/Title:General Partner
Date:06/11/2026
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
Kai Zheng
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng
Date:06/11/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement (filed herewith).

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

Categories

SEC Filings